Hims & Hers Expands into European Market with Zava Acquisition

Telehealth Giant Makes Strategic Move for International Growth

Hims & Hers Health, Inc., a leading telehealth and wellness company, has announced its intention to acquire European digital healthcare provider Zava in an all-cash deal. The acquisition, expected to close in the second half of 2025, marks a significant step in Hims & Hers' international expansion strategy and is set to broaden its reach in the European market.

Deal Details and Financial Implications

The acquisition comes on the heels of Hims & Hers raising $1 billion through convertible senior notes in mid-May, which the company earmarked for international expansion and artificial intelligence implementation. While the exact purchase price has not been disclosed, Hims & Hers plans to fund the acquisition from its balance sheet at closing.

The company projects that the Zava acquisition will be accretive to its earnings per share by 2026, signaling confidence in the deal's financial benefits. This move aligns with Hims & Hers' broader strategy to capitalize on the growing demand for personalized digital healthcare services globally.

Strategic Benefits and Market Expansion

The acquisition of Zava is expected to significantly bolster Hims & Hers' presence in Europe, adding over a million customers to its user base. The deal will facilitate the company's entry into new markets, including Germany, France, and Ireland, while also strengthening its position in the UK.

Andrew Dudum, founder and CEO of Hims & Hers, emphasized the universal demand for simplified, personalized healthcare. "By leveraging ZAVA's established European presence, cutting-edge technology, and deep customer understanding, we're poised to fundamentally transform access to care for millions across Europe," Dudum stated.

The company plans to maintain a localized approach, offering access to healthcare providers who speak the local language in Great Britain, Ireland, France, and Germany. This strategy aims to ensure a personalized experience for patients across diverse European markets.

Product Offerings and Future Plans

Hims & Hers will continue to offer its core products for sexual health, hair loss, mental health, and weight loss in the European market. The company has also hinted at the introduction of new features for its European customers, with announcements expected later in the year.

David Meinertz, co-founder and CEO of ZAVA, expressed enthusiasm about the merger, stating, "Together we'll pair ZAVA's trusted clinical services, established footprint, and deep understanding of the European healthcare landscape with the Hims & Hers experience to make affordable access to high-quality, personalized care the rule, not the exception."

As the digital healthcare landscape continues to evolve, this acquisition positions Hims & Hers to play a significant role in shaping the future of personalized, accessible healthcare across Europe.